Moreover, given that ABri and ADan deposition is a prominent feature in FBD and FDD, respectively, maturation of mutant-BRI2 (i.e. liberation of ABri and ADan) must occur, at levels sufficient to induce amyloidosis and as a consequence, significant amounts of mature functional BRI2 must be produced. The gene discussed is ITM2B; the disease is amyloidosis.